{"date":"2026-09-15","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6875-2026-09-15-2314-8dc9jo","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-09-15","time":"23:14:24","subject":"本公司吸入新藥L606用於治療PH-ILD之全球第三期臨床試驗(Re-Spire)獲中國NMPA核准執行","clause":"第53款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-09-15 23:14，「本公司吸入新藥L606用於治療PH-ILD之全球第三期臨床試驗(Re-Spire)獲中國NMPA核准執行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2026-09-15-1743-ozqyjx","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2026-09-15","time":"17:43:11","subject":"本公司受邀參加國票綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2026-09-15 17:43，「本公司受邀參加國票綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-15-1732-16swl74","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-15","time":"17:32:43","subject":"代重要子公司Alvogen Korea Holdings Ltd.公告召開2026年股東臨時會","clause":"第17款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-15 17:32，「代重要子公司Alvogen Korea Holdings Ltd.公告召開2026年股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-15-1732-1co4tu9","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-15","time":"17:32:19","subject":"代子公司Alvogen Korea Holdings Ltd.公告增資其子公司","clause":"第20款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-15 17:32，「代子公司Alvogen Korea Holdings Ltd.公告增資其子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-09-15-1630-1glq89c","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-09-15","time":"16:30:42","subject":"本公司受邀參加凱基證券舉辦之實體座談會","clause":"第12款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-09-15 16:30，「本公司受邀參加凱基證券舉辦之實體座談會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-09-15-1617-1z01b1v","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-09-15","time":"16:17:59","subject":"公告本公司115年8月份自結應收帳款餘額及回收情形","clause":"第53款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-09-15 16:17，「公告本公司115年8月份自結應收帳款餘額及回收情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-09-15-1558-bcafut","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-09-15","time":"15:58:52","subject":"公告本公司商務長(CBO)異動","clause":"第8款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-09-15 15:58，「公告本公司商務長(CBO)異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-09-15-1528-1jb4fb5","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-09-15","time":"15:28:02","subject":"公告本公司買回公司股份之累積金額達新台幣三億元以上","clause":"第35款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-09-15 15:28，「公告本公司買回公司股份之累積金額達新台幣三億元以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-15-1451-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-15","time":"14:51:00","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-15 14:51，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-09-15-1450-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-09-15","time":"14:50:37","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2026-09-15","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-09-15 14:50，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-09-15-1422-9e1stz","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-09-15","time":"14:22:46","subject":"本公司受邀參加統一綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-09-15 14:22，「本公司受邀參加統一綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}